Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct
Driving High Performance - Shortening study start-up and optimizing revenue generation
